共 8 条
[3]
*DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1
[5]
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug resistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials
[J].
LANCET,
2006, 368 (9534)
:466-475
[6]
Johnson Victoria A, 2007, Top HIV Med, V15, P119